Dixon MRI for Prostate Cancer

Recruiting in Palo Alto (17 mi)

Overseen byGaneshan Dhakshina Moorthy

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: M.D. Anderson Cancer Center

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial studies the use of magnetic resonance imaging (MRI) with Dixon based imaging sequences in detecting prostate cancer. MRI uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. Researchers hope to learn if using a modified MRI scan technique with Dixon based imaging sequencing will help to produce better images of prostate cancer than the standard of care MRI scan technique.

Eligibility Criteria

This trial is for men with biopsy-proven prostate cancer who have consented to participate, are scheduled for prostate removal surgery (prostatectomy), and a standard MRI scan. It's not open to those who've had hormone or radiation therapy affecting the pelvis or prostate, prefer other treatments over surgery, or can't have MRIs due to metal implants or pacemakers.

Inclusion Criteria

I have prostate cancer confirmed by biopsy and will have surgery to remove my prostate.

I am scheduled for a prostate MRI to check the cancer stage.

Patients who have signed their informed consent form to undergo the study

Exclusion Criteria

Contraindication to conventional MR imaging (e.g. metal implants, pacemaker, etc.)

I have had hormone therapy or radiation for my pelvic or prostate area.

I prefer not to have surgery for my prostate condition.

Participant Groups

The study is testing whether a modified MRI technique using Dixon based imaging sequences can provide better images of prostate cancer compared to the usual MRI scans. The goal is to see if this new scanning method improves the detection and visualization of prostate tumors.

1Treatment groups

Experimental Treatment

Group I: Diagnostic (standard MRI, Dixon MRI)Experimental Treatment2 Interventions

Patients undergo MRI with additional Dixon based sequences with fat and water over a total of 49 minutes.